Analyst - Pharmaceutical Sector, do you need a (bio) science degree?

Hello fellow monkeys,

I have a question regarding Equity Research Analysts covering the pharmaceutical sector:

-Do you need a degree in biology, medicine - or any medical science related degrees, in order to cover such an industry?

-Is it possible for me, as I study a Finance degree, to be able work as an analyst in this sector?

I have read many research reports on pharmaceutical companies and there were many technical terms which are related to the medical science field and could not be grasped by any outsiders...

 

no but it takes some time to grasp without a bio degree. Still - even bio students out of college will have a tough time comprehending everything as they study mostly theories and techniques of dead people whereas covering stocks is about being up to date on the newest technologies...

a science background is helpful, but understanding the business is really about understanding the process of approvals, improvement in resedarch techniques and basic understanding of drugs etc..

 
Best Response

I previously worked for an analyst who covered healthcare-related consumer products at one point in his career. He worked as an associate covering a different industry and was asked to help grow the new group. He noted it took longer to learn the industry-specific language but it's certainly possible. While being familiar with specific processes may be helpful (i.e. required approval steps for a medical device to yield results for intended use), the company will translate most of this for you. It's the analysts job to understand more of the company's operations and less of the product development.

Look at it semiconductors. An analyst doesn't necessarily need to know how to build a chip or know what a transistor but the analyst should analyze production rates, ASPs and other industry metrics. For telecom, this could be ARPU and churn rates. For retail, this could be comp, traffic, promotional cadence, etc. Some are easier to understand than others because we may experience these in our daily lives, i.e. promotions from retailers. Others would require a deeper understanding or at least some exposure in the field.

I believe firms look for those who have a degree because it shows that the candidate has the capacity to understand the industry-specific dense terms or, at least, is passionate about the field. All in all, it's just harder to prove to a recruiter why you're more capable than someone who has proven knowledge.

 

As a sell-side deal-making person who has done pharma deals, I think the important thing is the numbers. As your colleagues said, it's the business side that matters.

It helps to have the background knowledge and some companies like McKinsey (that produce horribly expensive pharma reports) target specifically grads with pharma academics. These consulting companies work with the buy-side, don't they? I can't remember, I mean ever, working with these specialist consultants.

From the sell-side perspective, we always rely on the buy-side to do more DD, to hire specialists and do more research before putting their money in the deal.

ER is about talking to people, right? When I was a student, I thought ER was about doing numbers and ratios, but there is no much of that.

 

R&D innovation is important for biopharma but not always the most cruicial - even big pharma companies regularly get slammed by the FDA for overlooking manufacturing. partnerships, taxes, M&A, financing are all equally important as an R&D pipeline for these businesses.

Also, most drugs and biotech solutions are pretty easy to understand if you took high school chemistry. The main thing about treatments you actually need to know aren't the chemical processes but really the consumer experience. cost of production, pricing power, effectiveness (measured in many diff ways), how strong people need it etc

 
  • Does a PhD in Life sciences + MBA need CFA to progress in career? Unlikely.

  • Do you think It's an interesting job for a PhD in life sciences ? Stupid question. Is it an interesting job for you?

  • Skills in biology are really useful? Could be - if you have the knowledge to determine whether a new product works or not.

  • What is the typical salary for an analyst in a BB? How long is a piece of string. Do a search in this forum.

  • and my last question.. Can ER allow to break into VC ? No, it's illegal.

thank you very much You're welcome.

 

Hi. I work in Biotech research, so I can give you honest answers

  • Does a PhD in Life sciences + MBA need CFA to progress in career? Yes, I will probably do this for a couple more years and then move to another industry.

  • Do you think It's an interesting job for a PhD in life sciences ? Skills in biology are really useful?

  • Yes, all the senior people are PhD's

  • What is the typical salary for an analyst in a BB?

  • and my last question.. Can ER allow to break into VC ?

  • Most people who leave, go into HF, but I assume that VC should be OK, too, depending on what firm you work for
 

Molestiae vel sit qui recusandae iste et. Minima dolorum est quibusdam sunt voluptas quae velit aspernatur. Aut et consequuntur illum impedit voluptatem quia odio modi. Commodi sequi sit dolorem autem magnam tenetur ducimus.

Career Advancement Opportunities

April 2024 Investment Banking

  • Jefferies & Company 02 99.4%
  • Goldman Sachs 19 98.8%
  • Harris Williams & Co. New 98.3%
  • Lazard Freres 02 97.7%
  • JPMorgan Chase 03 97.1%

Overall Employee Satisfaction

April 2024 Investment Banking

  • Harris Williams & Co. 18 99.4%
  • JPMorgan Chase 10 98.8%
  • Lazard Freres 05 98.3%
  • Morgan Stanley 07 97.7%
  • William Blair 03 97.1%

Professional Growth Opportunities

April 2024 Investment Banking

  • Lazard Freres 01 99.4%
  • Jefferies & Company 02 98.8%
  • Goldman Sachs 17 98.3%
  • Moelis & Company 07 97.7%
  • JPMorgan Chase 05 97.1%

Total Avg Compensation

April 2024 Investment Banking

  • Director/MD (5) $648
  • Vice President (19) $385
  • Associates (86) $261
  • 3rd+ Year Analyst (13) $181
  • Intern/Summer Associate (33) $170
  • 2nd Year Analyst (66) $168
  • 1st Year Analyst (205) $159
  • Intern/Summer Analyst (145) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
Betsy Massar's picture
Betsy Massar
99.0
3
BankonBanking's picture
BankonBanking
99.0
4
Secyh62's picture
Secyh62
99.0
5
kanon's picture
kanon
98.9
6
CompBanker's picture
CompBanker
98.9
7
dosk17's picture
dosk17
98.9
8
GameTheory's picture
GameTheory
98.9
9
Jamoldo's picture
Jamoldo
98.8
10
DrApeman's picture
DrApeman
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”